A major pharmaceutical company was developing a new therapeutic agent. As with most new drugs, tens of thousands of compounds had been synthesized and screened. Most of these compounds were found to have little activity for their intended use. The company did not however want to dispose of them, and so they were stored. An R&D director at the company believed that while these compounds might not be active for their intended use, that they might have antimicrobial activity. Westbury was contacted and developed a rapid protocol to quickly and effectively screen compounds for antimicrobial activity against a wide range of microorganisms. Several of the hundreds of compounds tested by us did in fact have antimicrobial activity and this was reported back to the company.

Tags: , ,


Westbury Diagnostics, Inc. is a full service organization which works with clients to generate solutions to problems in the bioscience industry. We specialize in unique niche projects that require a broad range of abilities under a single roof. We help identify issues or conflicts in your project, formulate solutions and develop them in house. Our clients seek custom R&D work, due diligence, or FDA guidance in the bioscience and venture capital sectors.

Recent Posts

Links